Navigation Links
AlphaRx provides update on Indaflex
Date:5/10/2010

HONG KONG, May 10 /PRNewswire-FirstCall/ - AlphaRx, Inc. (OTCBB: ALRX), has been advised by Cypress Biosciences ("Cypress"), its development partner for Indaflex, that Cypress is not funding development of Indaflex. Notwithstanding to the termination of all Indaflex activity in the U.S.A., AlphaRx continues to develop Indaflex for the Chinese market. AlphaRx is working diligently with its regulatory consultants in the preparation for submission of a CTA (clinical Trial Application) with the China SFDA in order to begin human trials in China. These preparations are proceeding on schedule.

About AlphaRx Inc.

AlphaRx is a specialty pharmaceutical company dedicated to developing proven therapies by reformulating FDA approved and marketed drugs which through the application of its proprietary site-specific nano drug delivery technology, offers improved medical benefits and a potential for significant commercial product development. The Company's product candidates address various pharmaceutical markets, including inflammation, stroke and pneumonia.


'/>"/>
SOURCE AlphaRx Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Golub Capital Provides Financing to Support The Recapitalization of Integrated DNA Technologies, Inc.
2. PharmAthene Reports Year-End 2009 Financial and Operational Results and Provides Update On Ongoing Litigation With SIGA Technologies
3. PDL BioPharma Announces Fourth Quarter and Full Year 2009 Financial Results and Provides First Quarter 2010 Revenue Guidance
4. IGEN Networks appoints directors and provides business update
5. Shire Provides Update on Biologics License Application (BLA) Filing for REPLAGAL(R) (agalsidase alfa) With the U.S. Food and Drug Administration (FDA)
6. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Fourth Quarter and Full Year Financial Results
7. Watching crystals grow provides clues to making smoother, defect-free thin films
8. Discovery provides new drug targets for malaria cure
9. BioMS Medical provides corporate update
10. Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe
11. PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... May 31, 2016 , ... The Academy of Model ... that will be on display Memorial Day through Labor Day 2016. Bill Chaffee’s Boeing ... Clark Chaffee. , Bill Chaffee won first place for Senior Scale Model at ...
(Date:5/27/2016)... ... ... Weeks after hosting a carpal tunnel syndrome workshop with Dr. Oz on ... of the Fitzmaurice Hand Institute, has announced the addition of MRI diagnostic imaging services ... only 1 of about 3 currently available in the United States. Developed specifically for ...
(Date:5/27/2016)... ... May 27, 2016 , ... Doctors in Italy, Japan, the ... on the BRCA-1 associated protein (BAP1) gene and its link to malignant mesothelioma. Surviving ... here to read the full article now. , The studies analyzed for the ...
(Date:5/27/2016)... YORK , May 27, 2016 ... but investors playing in this space know that volatility is ... morning,s featured companies on ActiveWallSt.com: Synta Pharmaceuticals Corp. (NASDAQ: ... ), Lpath Inc. (NASDAQ: LPTN ), and Heat ... and gain access to the technical alerts for these stocks ...
Breaking Biology Technology:
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
Breaking Biology News(10 mins):